|
|
|
LifeScienceHistory.com - Check us out on Instagram
New York Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing New YorkLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Mesoblast Limited
| | | Phone: | (212) 880-2060 | Fax: | (212) 880-2061 | Year Established: | 2004 | Ticker: | MSB | Exchange: | ASX | Main Contact: | Silviu Itescu, Ph.D., CEO | | Other Contacts: | Peter Howard, BSc, LLB (Hons), General Counsel Donna Skerrett, MD, MS, CMO Paul Hodgkinson, MA (Hons), FCA, CFO
| | Company Description | Mesoblast is a world leader in the development, manufacture, and commercialization of biologic products for the broad field of regenerative medicine. Mesoblast's patented Mesenchymal Precursor Cell (MPC) technology is being developed for a broad range of major clinical diseases, including inflammatory and immunologic conditions, diabetes and its complications, orthopedic spine conditions, and cardiovascular disorders. | |
|
|
|
|
|